Back to top
more

IDEXX Laboratories (IDXX)

(Delayed Data from NSDQ)

$656.16 USD

656.16
981,521

+0.65 (0.10%)

Updated Sep 19, 2025 03:59 PM ET

After-Market: $656.19 +0.03 (0.00%) 7:58 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy23.64%
2Buy17.83%
3Hold9.69%
4Sell5.29%
5Strong Sell2.54%
S&P50011.29%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

3-Hold of 5     3    

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

  • Value Score A
  • Growth Score A
  • Momentum Score A
  • VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

D Value B Growth D Momentum D VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Top 38% (92 out of 245)

Industry: Medical - Instruments

Zacks Premium FeatureView All Zacks #1 Ranked Stocks

Zacks News

Zacks Equity Research

Medical Products Earnings Due on Aug 1: IDXX, RMD

by Zacks Equity Research

There are some powerful long-term tailwinds of the medical device industry which have been a major driving force behind the sector's impressive performance over the past few quarters.

    Zacks Equity Research

    Why Earnings Season Could Be Great for IDEXX Laboratories (IDXX)

    by Zacks Equity Research

    IDEXX Laboratories (IDXX) is seeing favorable earnings estimate revision activity as of late, which is generally a precursor to an earnings beat.

      Zacks Equity Research

      MedTech Stocks to Top Q2 Estimates

      by Zacks Equity Research

      Most of the MedTech majors are lined up to report their earnings results over the next week.

        Zacks Equity Research

        What's in the Offing for Hologic (HOLX) in Q3 Earnings?

        by Zacks Equity Research

        Hologic's (HOLX) gain through product launch and Cynosure integration may get hampered by a dull Cytology performance.

          Zacks Equity Research

          IDEXX Laboratories (IDXX) Q2 Earnings: A Beat in the Cards?

          by Zacks Equity Research

          IDEXX Laboratories' (IDXX) Companion Animal Group business might drive its performance in Q2.

            Zacks Equity Research

            DENTSPLY SIRONA Renews Canadian Distribution Agreement

            by Zacks Equity Research

            DENTSPLY SIRONA Inc. (XRAY), a dental solutions company, recently announced the renewal of an existing distribution agreement with Henry Schein Canada, Inc.

              Zacks Equity Research

              Luminex Gets CE Mark for ARIES Norovirus Assay, Shares Rally

              by Zacks Equity Research

              Shares of Luminex Corporation (LMNX) gained 1.5% to close at $21.38 after the company announced the receipt of CE-IVD mark for the ARIES Norovirus Assay.

                Zacks Equity Research

                IDEXX Well-Poised on Strong Fundamentals, Global Growth

                by Zacks Equity Research

                On 29, we issued an updated research report on IDEXX Laboratories, Inc. (IDXX).

                  Zacks Equity Research

                  CryoLife Hits a 52-Week High: What's Driving the Stock?

                  by Zacks Equity Research

                  Leading medical device and tissue processing company, CryoLife, Inc. (CRY) rallied to a new 52-week high of $20.20 on Jun 27, eventually closing a little lower at $19.65.

                    Zacks Equity Research

                    Medidata (MDSO), inVentiv Enter Into Multi-Year Partnership

                    by Zacks Equity Research

                    Medidata Solutions Inc. (MDSO) recently announced that it has entered into a multi-year partnership with inVentiv Health, a leading biopharmaceutical professional services company.

                      Zacks Equity Research

                      Merit Medical Embosphere Gets FDA de novo Classification

                      by Zacks Equity Research

                      Merit Medical Systems, Inc. (MMSI) recently announced the receipt of 513(f)(2) (de novo) classification for Embosphere Microspheres from the FDA to expand its indication in the prostatic artery embolization (PAE) space.

                        Zacks Equity Research

                        Evolent Health (EVH) Prices 4.5M Follow-On Share Offering

                        by Zacks Equity Research

                        Evolent Health, Inc. (EVH) recently announced the pricing of its follow-on public offering of 4.5 million shares of Class A common stock at $25.90 per share.

                          Zacks Equity Research

                          PRA Health Hits a 52-Week High on Strategic Acquisitions

                          by Zacks Equity Research

                          Leading global contract research organization PRA Health Sciences (PRAH) rallied to a new 52-week high of $78.30 on Jun 21, closing a little lower at $77.21.

                            Zacks Equity Research

                            Luminex (LMNX) Banks on Portfolio Strength, View Impressive

                            by Zacks Equity Research

                            On Jun 21, we issued an updated research report on Austin, TX-based Luminex Corp (LMNX) -- a manufacturer and marketer of proprietary biological testing technologies with applications throughout the life sciences and diagnostics industry.

                              Zacks Equity Research

                              Medidata Solutions (MDSO) Set to Join the S&P 400 Index

                              by Zacks Equity Research

                              Medidata Solutions Inc. (MDSO), a leading global provider of clinical development solutions, is scheduled to join the coveted S&P 400 benchmark before the opening bell on Jun 26.

                                Zacks Equity Research

                                PRA Health (PRAH) Shares Rally on Partnership with Jumo

                                by Zacks Equity Research

                                Shares of PRA Health (PRAH) rallied 2.3% to close at $75.50, following PRA Health's recently announced partnership with Jumo, a global provider of educational health care information.

                                  Zacks Equity Research

                                  Neogen Offers NeoSeek Genomic Services to Ensure Food Safety

                                  by Zacks Equity Research

                                  Headquartered in Lansing, MI, Neogen Corporation (NEOG) recently announced the availability of next generation sequencing services for the food industry.

                                    Zacks Equity Research

                                    DENTSPLY (XRAY) Renews Partnership with Pacific Dental

                                    by Zacks Equity Research

                                    DENTSPLY SIRONA Inc. (XRAY), a dental solutions company, recently announced that it has renewed its strategic partnership with Pacific Dental Services, LLC.

                                      Zacks Equity Research

                                      Pacific Biosciences (PACB) Prices Offering of Common Stock

                                      by Zacks Equity Research

                                      Pacific Biosciences of California, Inc. (PACB) recently announced that it has priced its underwritten public offering of 15.4 million shares of its common stock.

                                        Zacks Equity Research

                                        Varian Showcases Halcyon System at DEGRO Meet, Stock Up

                                        by Zacks Equity Research

                                        Shares of Varian Medical Systems Inc. (VAR) rallied almost 1% after the company showcased a new Halcyon radiotherapy treatment system at the 2017 DEGRO meeting, the German radiation oncology society, in Berlin.

                                          Zacks Equity Research

                                          TransEnterix Sells Surgery System to Japanese University

                                          by Zacks Equity Research

                                          TransEnterix, Inc. (TRXC), a global medical technology company, recently announced that it has sold a Senhance Robotic Surgery System to a Japanese customer.

                                            Zacks Equity Research

                                            Baxter-Dorizoe Ink Deal to Expand Generic Injectables Line

                                            by Zacks Equity Research

                                            Deerfield, IL-based Baxter International Inc. (BAX), a global medical technology company, recently signed an agreement with India-based Dorizoe Lifesciences for expansion of its generic injectables pipeline.

                                              Zacks Equity Research

                                              CONMED (CNMD) Hits a 52-Week High: What's Driving the Stock?

                                              by Zacks Equity Research

                                              Shares of Utica, NY-based leading medical technology player, CONMED Corporation (CNMD) rallied to a new 52-week high of $52.79 on Jun 13, closing a little lower at $52.49.

                                                Tirthankar Chakraborty headshot

                                                5 Top Performing Efficient Stocks to Buy Now

                                                by Tirthankar Chakraborty

                                                A favorable efficiency level provides impressive returns as it is positively correlated with the company's price performance

                                                  Zacks Equity Research

                                                  IDEXX Laboratories Global Growth Solid amid Currency Woes

                                                  by Zacks Equity Research

                                                  On May 29, we issued an updated research report on leading molecular diagnostic company, IDEXX Laboratories, Inc. (IDXX).